PepGNP-COVID19 Vaccine

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PepGNP-COVID19 Vaccine, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults [Phase 1]